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Abstract
Bacteria form complex and highly elaborate surface adherent communities known as biofilms which are held together by a
self-produced extracellular matrix. We have previously shown that by adopting a biofilm mode of existence in vivo, the
Gram negative bacterial pathogens Bordetella bronchiseptica and Bordetella pertussis are able to efficiently colonize and
persist in the mammalian respiratory tract. In general, the bacterial biofilm matrix includes polysaccharides, proteins and
extracellular DNA (eDNA). In this report, we investigated the function of DNA in Bordetella biofilm development. We show
that DNA is a significant component of Bordetella biofilm matrix. Addition of DNase I at the initiation of biofilm growth
inhibited biofilm formation. Treatment of pre-established mature biofilms formed under both static and flow conditions
with DNase I led to a disruption of the biofilm biomass. We next investigated whether eDNA played a role in biofilms
formed in the mouse respiratory tract. DNase I treatment of nasal biofilms caused considerable dissolution of the biofilm
biomass. In conclusion, these results suggest that eDNA is a crucial structural matrix component of both in vitro and in vivo
formed Bordetella biofilms. This is the first evidence for the ability of DNase I to disrupt bacterial biofilms formed on host
organs.
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Introduction
The genus Bordetella currently consists of nine species of Gram
negative bacteria. Some members of this genus are known
mammalian and avian pathogens that colonize the respiratory
tracts of humans, animals and birds. B. pertussis and some strains of
B. parapertussis are the causative agents of whooping cough in
humans, while B. bronchiseptica causes multiple respiratory syn-
dromes and diseases in a wide variety of animal species, including
dogs, pigs, cats, rabbits and rats. B. avium infects commercially
grown turkeys as well as wild and domesticated birds [1,2,3].
A hallmark of B. bronchiseptica and B. avium infections is long-
term to life-long asymptomatic carriage. Although vaccination
considerably decreases mortality and severity of the respiratory
disease, B. bronchiseptica and B. avium continue to circulate and
persist in mammalian and avian species. B. bronchiseptica is
frequently isolated from the nasal cavities of vaccinated animals
suggesting that vaccines fail to protect animals from infections [4].
Similarly, despite excellent vaccine coverage, pertussis remains
endemic in the USA and many European countries. Outbreaks of
pertussis are observed frequently. It is becoming clear that the
current pertussis vaccines, although effective against severe
symptoms of the disease, do not prevent prolonged colonization.
B. pertussis continues to circulate by residing mainly in the
nasopharynx of adolescents and adults, resulting in asymptomatic
or milder infections [5,6,7].
Despite enhanced awareness of the need for increased and
efficient detection [8], a large number of adult pertussis cases often
remain undiagnosed [6,9]. Infected individuals silently harbour
the pathogen, resulting in heightened transmission risk to
susceptible children [10,11]. Intra-familial and other modes of
person-person pertussis transmission have been documented
[10,12]. In a recent population-based study of families having an
infant diagnosed with pertussis, 53% of the household contacts
had laboratory-confirmed pertussis. Strikingly, in 60% of the
households, the source of transmission to infants was clearly
established to be one of the family members [13].
One proposed hypothesis to explain the survival and continued
persistence of Bordetella Spp. in the mammalian nasopharynx is that
these organisms form surface-adherent communities known as
biofilms [14,15]. Recent studies from our laboratory and others
have supported this hypothesis by demonstrating that both B.
pertussis and B. bronchiseptica are capable of forming biofilms on
abiotic surfaces [16,17,18,19] and in the mouse respiratory tract
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16861[14,15]. The ability to form biofilms in mice suggests a role for this
mode of existence during human infections. In this context,
clusters and tangles (reminiscent of biofilms) of B. pertussis adherent
to ciliated cells in explant cultures and tissue biopsies of pertussis
patients have been demonstrated [20,21,22].
Biofilms are defined as a community of surface-adherent
bacteria encased in a self-produced polymeric matrix that holds
the cells together. Limitations of oxygen within the biofilm matrix,
altered metabolic rate of the surface-adherent organisms com-
bined with the function of the matrix as a physical barrier results in
biofilm cells becoming resistance to killing by host defenses,
antimicrobial compounds and surfactants [23,24]. While the
composition of biofilm matrices varies depending upon the
bacterial species, growth media or the environmental conditions,
it is often composed of a polysaccharide biopolymer along with
proteins and extracellular DNA (eDNA) [25,26,27]. eDNA has
now emerged as one of the major components the biofilm matrix
of many bacteria and has been shown to perform diverse functions
in promoting the biofilm mode of existence [27,28,29,30,31,32].
Previous studies from our laboratory and others have clearly
established that, like some bacterial pathogens, Bordetella biofilm
development is also mutifactorial [24,26]. We have shown that the
exopolysaccharide Bps is a component of the biofilm matrix and is
essential for maintaining the biofilm architecture in both B.
bronchiseptica and B. pertussis [14,15,17]. Others have examined
mutant strains containing deletions in outermembrane proteins
that show biofilm formation in the animal pathogen B. bronchiseptica
is protein-mediated [18]. In this report, we demonstrate that DNA
is a significant component of the Bordetella biofilm matrix. We show
that DNase I not only led to inhibition of biofilm growth, but also
disrupted established mature biofilms formed under both static
and continuous flow conditions. These results provide strong
evidence for the crucial function of eDNA in maintaining the
integrity of laboratory biofilms formed on artificial surfaces.
Despite the wealth of in vitro data on the different bacterial
biofilm developmental programs and the mechanisms by which
many bacterial factors contribute to these processes, large gaps
exist in the research on biofilms formed on host organs. Very few
animal models are able to mimic the characteristics of biofilms
formed in vitro. We have recently established an in vivo model of
Bordetella biofilms in the mouse respiratory tract [14,15]. One of
the strengths of this model is that the Bordetella microcolonies
attached to the nasal epithelium are surrounded by an
extracellular matrix composed of the Bps polysaccharide, thereby
satisfying the definition of in vivo biofilms [23,33]. To examine if
DNA contributed to the structural stability of these nasal biofilms,
we treated nasal septa from mice infected with B. bronchiseptica and
B. pertussis with DNase I. Immunofluorescence and scanning
electron microscopic examination revealed that this treatment
resulted in considerable dissolution of nasopharyngeal biofilms.
These results suggest that DNA promotes the stability and
development of Bordetella biofilms in the upper respiratory tract.
Materials and Methods
Bacterial strains and culture conditions
Wild type strain (RB50) of B. bronchiseptica was grown in Stainer-
Scholte (SS) broth [57]. For culturing B. pertussis strain (Bp536), the
SS medium was supplemented with heptakis (6-di-O-methyl-b-
cyclodextrin) [16]. For culturing strains harboring the pTac-Gfp
plasmid, the SS medium was supplemented with 50 mg/ml of
chloramphenicol [17]. All strains were maintained on Bordet-
Gengou (BG) agar supplemented with 7.5% defibrinated sheep
blood and streptomycin (50mg/ml).
Growth and treatment with DNase I of static biofilms
Biofilms were cultivated in microtitre plates at 37uCa s
described previously [17]. Briefly overnight grown culture of B.
bronchiseptica was inoculated in the wells of a 96 well microtitre
plate at OD600 of 0.05 followed by addition of either DNase I
reaction buffer (10mM Tris-HCl, pH 7.5, 50% glycerol, 10mM
MgCl2), or with DNase I (40 Kuntz units/ml)(Sigma or Promega)
resuspended in the DNase I reaction buffer. A time course of
biofilm formation was performed over 48h under static conditions.
At each time point, non attached planktonic bacteria were
removed and the plate was rinsed thoroughly. The biofilms were
stained with 100ml of 0.1% crystal violet solution by incubating at
room temperature for 30 min. After washing, the attached crystal
violet was solubilized in 200 ml of 95% ethanol and transferred to a
new polystyrene plate and absorbance was measured at 540nm. A
similar procedure was employed for B. pertussis but with some
modifications. The biofilms were grown in 12 well tissue culture
plates and these plates were inoculated with B. pertussis cultures
grown for 3–4 days [15].
Reversibility of DNase I inhibition
B. bronchiseptica biofilms were inoculated as described above with
DNase I or media alone. After 24h, the media was removed from
one set of six wells containing DNase I as well as the mock wells
and replaced with fresh media. The original media and DNase I
was left undisturbed in an additional set of six wells. All samples
were then incubated at 37uC for an additional 24h before
processing with crystal violet as described above.
DNase I stability assays
DNase I from both Sigma and Promega were incubated at 37uC
for 48h in their appropriate reaction buffer at a concentration of
100 Kuntz units/ml. Following the incubation, approximately
1 mg of genomic DNA from RB50 was added. The reactions were
continued for 3h at 37uC. Samples were then run on a 1% agarose
gel and stained with ethidium bromide for visualization of the
DNA.
Growth and treatment with DNase I of pre-existing static
biofilms
B. bronchiseptica cultures were inoculated into 96 well plates in a
100ml volume at an OD600 of 0.05. Biofilms were then allowed to
form for 48h at 37uC under static conditions. After 2 days, the
biofilms were washed once with sterile PBS before the addition of
either 100ml of sterile PBS, PBS with reaction buffer, PBS with 40
Kuntz units/ml of DNase I, PBS with 40 Kuntz units/ml of heat
inactivated DNase I, or PBS with reaction buffer and DNase I for
2h at 37uC. All wells were then washed 3 times and then treated
for crystal violet staining as described above.
Mid log phase (OD600,0.7–1.0) grown cultures of B. bronchi-
septica and B. pertussis carrying the pTac-Gfp construct were
inoculated in two chambered coverslips and cultured in SS broth
with chloramphenicol. 12mm glass coverslips were partially
submerged in the culture and allowed to incubate for 48h with
B. bronchiseptica or 96h with B. pertussis at 37uC under static
conditions. Biofilms formed at the air liquid interface of the
coverslips were gently rinsed with PBS to remove any unattached
bacteria, followed by incubation with DNase I for 30 min or
90 min at 37uC. Coverslips were gently rinsed with PBS and
mounted with ProLong gold antifade reagent (Invitrogen),
followed by visualization using a Zeiss LSM 510 confocal scanning
laser microscope. Coverslips were incubated with PBS as a
negative control and treated in a similar manner.
eDNA and Nasal Biofilms of Bordetella
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Biofilms were grown in three chambered flow cells (Stovall), which
were aseptically inoculated with 200ml of mid log phase culture
(OD600,0.7–1.0) of Gfp-tagged RB50cells using sterile 25 5/8 gauge
needles, followed by incubation at 37uC for 2h. Subsequently flow of
the SSmedia was initiated at a constant rate of 0.3ml/min. At various
time points (6, 72 and 120h), flow was stopped and the biofilms were
treated with 66 Kuntz units/ml of DNase I supplemented with 5mM
MgCl2 for 90 min. After this incubation, the channels were rinsed
gently by resuming the flow at the previous rate. Biofilm growth and
accumulation of extracellular DNA were visualized under 636water
objective by CSLM. Extracellular DNA in the biofilm was stained
with 2mM DDAO [7-hydroxy-9H-(1, 3-dichloro-9, 9 dimethylacri-
din-2-one)] for 30 min at 37uC.
Ethics statement
Animal husbandry and experimental procedures were per-
formed in accordance with Public Health Service policy and the
recommendations of the Association for Assessment and Accred-
itation of Laboratory Animal Care and approved by the Wake
Forest University Health Sciences Institutional Animal Care and
Use Committee (protocol #s A09-146, A06-153, A09-024).
In vivo biofilm formation on the mouse nasal septum,
DNase I treatment and immunofluorescence staining
Five to six week-old female C57BL/6 mice (Jackson Laboratory)
were partially anesthetized using isoflurane (Butler) and infected
intranasally with ,5610
5 cfus of RB50 or Bp536 in a 50ml
droplet. At 15 and 19 days after inoculation with RB50 or Bp536,
the nasal septa were excised and cut into two equal parts. One half
was incubated with PBS while the other half was treated with 100
Kuntz unit/ml of DNase I supplemented with 5mM MgCl2 for
90 min at 37uC. Both nasal sections were then briefly washed with
PBS before fixation with 2.5% glutaraldehyde.
Nasal septa were stained as described previously [58], Briefly,
fixed mouse nasal septa were rinsed with PBS and blocked with
5% normal donkey serum in PBS for 30 min. Immunochemical
staining of RB50 was performed using a polyclonal mouse sera
raised against a Bvg
+ phase locked derivative of RB50. For B.
pertussis biofilms, polyclonal mouse sera raised against Bp536 was
used. Both sera were used at a 1:1000 dilution in PBS. The nasal
septa were incubated at room temperature for 2h. After multiple
washes with PBS, nasal septa were incubated with a 1:2000
dilution of goat anti-mouse antibody conjugated to Alexa fluor 488
for 1.5h. Samples were washed with PBS and permeabilized with
0.1% Triton X-100 for 5 min, followed by staining with 1:40
dilution of phalloidin conjugated with Alexa fluor 633 for 30 min
for visualization of eukaryotic F actin. Samples were washed again
with PBS and mounted using ProLong Antifade gold reagent
(Invitrogen) according to manufacturer’s instructions, and stored
in the dark to dry. The slides were viewed on a Zeiss 510 confocal
laser scanning microscope.
Scanning Electron microscopy (SEM)
Nasal septa harvested from infected or naı ¨ve mice were treated
with either DNase I (as described above) or PBS as a negative
control. Samples were gently rinsed with PBS after treatment
followed by fixation with 2.5% glutaraldehyde for 1h followed by
routine processing for SEM as described previously [16].
Statistical analysis
All statistics were performed using the Student’s t-test and were
determined to be significant if P,0.05.
Results
The Bordetella biofilm matrix contains DNA
In our ongoing studies focused towards identifying the
constituents of the Bordetella biofilm matrix, we determined
whether DNA is a component of the biofilm matrix. GFP
expressing cells were inoculated in chambered coverslips and
allowed to form biofilms under dynamic flow conditions. After 72h
of flow, the biofilms were stained with DDAO which binds to
extracellular DNA (eDNA) or DNA inside the cells that have
compromised membranes [34]. The results showed that biofilms
formed by the wild type strain of B. bronchiseptica, RB50 (Fig. 1, top
panels) were mainly composed of cells which were not stained by
DDAO, and thus have impermeable membranes. In addition to
the green-staining live cells, bright red-staining dead cells were
observed along with a more diffuse weaker red stain which is
indicative of eDNA.
Similar to B. bronchiseptica, B. pertussis biofilms exhibited both
bright red-staining cells and a comparatively more diffuse weaker
red stain interspersed among the GFP-expressing live cells (Fig. 1,
bottom panels). This staining pattern is similar to eDNA detected
in other organisms such as Enterococcus, Listeria, and Staphylococcus
[35,36,37]. Taken together, these results suggest that DNA is a
component of biofilms formed by both B. bronchiseptica and B.
pertussis.
Extracellular DNA is required for biofilm formation and
stability
We hypothesized that by acting as a structural component,
DNA promotes biofilm stability. If this is the case, we reasoned
that removal of extracellular DNA from the biofilm matrix, by
treatment with DNase I, will lead to a reduction in the formation
of biofilms. Thus, we examined the ability of DNase I to inhibit
biofilm formation of both B. bronchiseptica (Fig. 2A) and B. pertussis
(Fig 2B). Presence of DNase I in the culture medium at the time of
inoculation resulted in a time-dependent effect on the ability of
both the species to form biofilms. At the early time-point of 6h,
addition of DNase I had no significant impact in inhibiting biofilm
growth (Fig. 2). In contrast, at 12h or later of biofilm growth,
DNase I significantly impaired the ability of both RB50 and
Bp536 to form biofilms. These results suggest that while DNase I
does not impede initial steps of biofilm development, it inhibits the
steps of biofilm development that occur after 6h.
We performed several control experiments to ensure that the
observed inhibitory effect was due to DNase I and not due to
contaminating factors. Highly purified DNase I from another
vendor (See Materials and Methods) resulted in similar levels of
inhibition (Fig. S1). Incubation with either the DNase I reaction
buffer (Fig. 2, black bars) or the heat inactivated enzyme did not
result in any significant effect on biofilm formation (Fig. 3). The
observed inhibition was also not due to a general bactericidal or
bacteriostatic effect of DNase I, since the wild type strain showed
similar growth in batch culture irrespective of the addition of
DNase I (Fig. S2).
To determine whether the inhibitory effect of DNA on biofilm
formation is reversible, we cultured RB50 in the presence of
DNase I for 24h, washed with PBS to remove the enzyme followed
by incubation in the culture medium for another 24h. As shown in
Fig. S3, an increase in the levels of crystal violet staining was
observed, suggesting that biofilm formation can progress after the
removal of DNase I. We also determined that the DNase I used in
these experiments was enzymatically active after 48h of incubation
at 37uC, suggesting that biofilm formation at the extended time
points involves an eDNA-dependent mechanism (Fig. S4).
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To further characterize the role of eDNA in Bordetella biofilms,
specifically its contribution to the development of late stage
biofilms, we determined if DNase I can disrupt statically
established mature biofilms.
Microtitre biofilm assays
Fig. 3 shows 48h biofilms formed in microtitre plates treated for
2h with DNase I. It is clear that incubation of these surface-
associated biofilms with DNase I resuspended in the reaction
buffer caused significant detachment. In control experiments,
incubation with PBS alone, with PBS containing the DNase I
reaction buffer, or with DNase I resuspended in PBS did not result
in any significant removal of these biofilms from the surface. The
failure of DNase I in PBS to have any effect on biofilm disruption
is consistent with the requirement of cations for optimum activity
of this enzyme.
Microscopic analyses
To visualize the effect of DNase I on impacting biofilm
structure, we continued this experiment with biofilms of GFP-
expressing cells formed on glass coverslips in biphasic cultures. For
B. bronchiseptica, the biofilms were grown for 48h followed by
incubation with or without DNase I for either 30 or 90 minutes. In
the absence of DNase I, the glass coverslip was extensively
colonized resulting in the visualization of a thick layer of cells at
the air-liquid interface (Fig. 4A). DNase I treatment for 30 min led
to the dissolution of the preformed bacterial films and the cells
existed in patchy localized clusters (Fig. 4A). On longer incubation
with DNase I, we found that large areas of the coverslips were
essentially devoid of bacterial cells, suggesting significant detach-
ment of the biofilm biomass (Fig. 4A).
Because B. pertussis has a longer generation time [38], we treated
B. pertussis biofilms established for 4 days with DNase I. We have
previously observed that at this time point, B. pertussis biofilms have
defined architecture and reach structural maturity [15]. Treat-
ment of preformed B. pertussis biofilms with DNase I resulted in
dissolution of the biofilm (Fig 4B). Similar to that observed in
Fig. 3, incubation with DNase I reaction buffer only did not have
any visible effect on the formation of these biofilms (Fig. 4B).
These results suggest that DNase I leads to detachment of
preformed biofilms of both B. bronchiseptica and B. pertussis. The
effect of DNase I on established biofilms was further quantified
with the COMSTAT software package. This analysis revealed that
DNase I treatment resulted in a drastic reduction in both the
average and maximal thickness of the biofilms formed by both B.
bronchiseptica and B. pertussis (Table 1).
Taken together, results presented so far suggest that in the
presence of DNase I, while bacteria were able to attach to the
surface, they failed to form stable biofilms. These results also
indicate that eDNA is a crucial structural component of the
Bordetella biofilm matrix and its removal through DNase I
treatment disrupts the integrity of established biofilm.
Extracellular DNA is crucial for biofilm maturation under
hydrodynamic conditions
Biofilms grown under static conditions often lack or have less of
the characteristic architecture compared to those grown under
Figure 1. Bordetella biofilms contain eDNA. Three day old biofilms of B. bronchiseptica strain RB50 (upper panels) and B. pertussis strain Bp536
(lower panels) were stained with DDAO. CLSM images of live GFP expressing cells (green) and DDAO stained eDNA (diffuse red) or dead cells
(punctuate red) are shown. Yellow appearance indicates the presence of both live cells and eDNA. The images shown are representative of three
independent experiments.
doi:10.1371/journal.pone.0016861.g001
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PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e16861Figure 2. DNase I inhibits Bordetella biofilm formation. The indicated strains were grown in 96 well microtitre plates for RB50 or 12 well plates
for Bp536 for designated time points in SS medium supplemented with either DNase I resuspended in the reaction buffer or the reaction buffer
alone. Wells were rinsed and stained with crystal violet followed by quantification of bound crystal violet as described in Materials and Methods. Each
data point is the average of six wells, and error bars indicate the standard deviation. Representative data from one of at least three independent
experiments are shown. Asterisks designate a value of P,0.05 (students t-test).
doi:10.1371/journal.pone.0016861.g002
Figure 3. DNase I leads to the disruption of established Bordetella biofilms grown in microtitre plates. Preformed 48h RB50 biofilms
grown in 96 well plates were rinsed with PBS followed by incubation with PBS, PBS and reaction buffer, PBS and DNase I, PBS and heat inactivated (HI)
DNase I, or PBS with reaction buffer and DNase I. Biofilm formation was then quantitated via crystal violet staining. Each point is an average of at least
6 wells, and error bars indicate the standard deviation. Asterisks designate a value of P,0.05 (students t-test).
doi:10.1371/journal.pone.0016861.g003
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Bordetella biofilms formed under shear conditions appear in the
form of pillars and towers with distinctive water channels [15,17].
Thus, we examined whether eDNA is critical for the stability of
structured biofilms formed under hydrodynamic conditions. GFP
expressing B. bronchiseptica cells were inoculated into chambered
flow cells and imaged using CLSM at an early (6h), middle (72h)
and at late (120h) time-points during biofilm development. The
presence of DNA in the biofilms was tracked using DDAO.
At the early time point of biofilm formation, bacteria existed
mainly in diffuse thin patches with large areas of coverslips
remaining free of bacterial cells. At this time point, we were unable
to detect significant levels of DNA (Fig. 5). At 72h, the biofilm
increased in thickness and density with the emergence of some
structural features in the form of thin closely clustered spikes or
pillars. At this stage of biofilm formation, DNA was present in low
but detectable levels. Dramatically at 120h of growth, the bacterial
cells displayed attributes of highly structured biofilms with
appearance of thick dome shaped pillar structures and water
channels. Staining with DDAO revealed that this biofilm
contained large amounts of DNA as indicated by yellow staining
(Fig. 5). Unlike that observed with other bacteria, DNA did not
appear to be localized at specific regions of the dome shaped
biofilm structure [34,36]. Instead DNA was found to be
distributed throughout the biofilm. Note that these images are
Z-reconstructions of multiple frames of the biofilms formed in the
flow cell. Due to the compression and overlay of multiple images,
colocalization of the red and green stains will occur. Thus, the
yellow staining is indicative of eDNA closely associated with the
GFP expressing bacteria.
Immediately after initial imaging of the bacterial cells and DNA,
biofilms formed at the different time-points were treated with
DNase I and then re-imaged. As shown in Fig. 5, upon DNase I
treatment, there was very little effect on the biofilms formed at 6h,
further confirming that eDNA plays only a minor role in the
initiation of biofilm development. COMSTAT analysis also
confirmed that there were no obvious differences between the
DNase I treated and mock treated 6h biofilms, since for both the
samples the average and maximum thickness was approximately
2.0 mm and 11 mm, respectively. On treatment of 72h biofilms
with DNase I, we found that many areas of the coverslips were
unoccupied suggesting surface detachment of bacterial cells. For
the remaining biofilm that was resistant to DNase I treatment, the
spike-like structures observed at this time point were reduced in
Figure 4. DNase I leads to the disruption of established Bordetella biofilms grown on glass coverslips under static conditions.
Biofilms were grown on glass coverslips for 48h for RB50 (A) and 96 h for Bp536 (B). The coverslips were gently rinsed followed by treatment with
DNase I for either 30min or 90min. The cells were tagged with GFP and thus are green. For each micrograph, the middle panel represents the x-y
plane, and the adjacent top and side panels represent the x-z and y-z planes, respectively. The images of a biofilm not treated with DNase I and
treated only with DNase I buffer are also depicted. CLSM was utilized to image the biofilms.
doi:10.1371/journal.pone.0016861.g004
Table 1. COMSTAT analysis of statically grown Bordetella





RB50 No Treatment 27.3 28.8
RB50 30 min DNase I 4.5 19.2
RB50 90 min DNase I 5.6 13.6
Bp536 No Treatment 15.7 17.0
Bp536 30 min DNase I 0.05 3.0
RB50 DNase I Buffer Alone 22.9 26.1
doi:10.1371/journal.pone.0016861.t001
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severely disrupted by DNase I leading to a complete dissolution of
the architecture and integrity of the biofilms. Only a few regions of
the coverslip were observed to have attached bacteria with no
apparent biofilm architecture. As determined by COMSTAT
analyses, the average biofilm thickness was reduced from 6.5 mm
to 4.0 mm and the maximal thickness was reduced from 16.0 mm
to 6.0 mm. In combination, these results suggest that DNA is a
central component that promotes the stability of Bordetella biofilms
formed on artificial surfaces.
DNase I treatment disrupts Bordetella biofilms formed in
the mouse nose
There is no information available on whether eDNA contributes
to the structural stability of in vivo biofilms formed in mammalian
hosts. Extracellular DNA was recently visualized in H. influenzae
biofilms formed in the chinchilla middle ear [39]. Although
treatment with DNase I led to the removal of DNA, mature
biofilms containing viable bacteria were still visible [39]. Because
DNase I disrupted highly-structured Bordetella biofilms formed on
abiotic surfaces, we hypothesized that eDNA will also be critical for
structural stability of nasal biofilms. Thus, we determined whether
DNaseI treatment disruptedbiofilms formed on the nasalseptum of
a mouse intranasally inoculated with Bordetella. Nasal septa were
harvested from mice infected with B. bronchiseptica for 15 days or B.
pertussis for 19 days and treated with either DNase I or with the
DNase I reaction buffer. Bordetella biofilms formed on these tissues
were then visualized by CSLM as described in the Materials and
Methods. Microscopic analysis revealed the presence of bacteria in
the form of scattered mat like structures on nasal epithelia
represented by the green staining bacteria on the surfaces of the
red staining epithelium (Fig. 6). Treatment with DNase I resulted in
a fluorescent image where the vast majority of staining indicative of
only the nasal epithelia was visible. Only a few patches of green
fluorescence, indicative of bacterial cells, were observed for RB50,
whereas no green fluorescence was observed for Bp536 (Fig. 6).
An alternate explanation for the above outcome is that
treatment with DNase I is somehow interfering with the
recognition of the bacterial strains by the rat anti-Bordetella serum,
resulting in the inability to visualize the bacterial cells. To address
this, we treated in vitro grown strains with DNase I followed by
immunofluorescence staining. Microscopic observations revealed
that there was no apparent reduction in the fluorescence of the
bacterial cells as a result of DNase I treatment (data not shown).
Figure 5. Susceptibility of flow cell biofilms to DNase I. Representative z-reconstructions of RB50 biofilms grown under flow conditions for 6,
72, or 120h and imaged using CLSM for live GFP expressing cells (green) and eDNA stained with DDAO (red or yellow with co-localization). The image
of untreated biofilms (left panels) were taken immediately prior to incubation with DNase I and the images of same biofilms treated with DNase I for
1.5h (left panels). Images shown here are representative of two independent experiments.
doi:10.1371/journal.pone.0016861.g005
Figure 6. DNase I disrupts established biofilms of B. bronchiseptica and B. pertussis formed in the mouse respiratory tract. CLSM
images of biofilms harvested from mouse nose 15 and 19 days postinoculation with RB50 (top) or Bp536 (bottom), respectively. The harvested nasal
septum was excised into two equal parts and incubated either with DNase I buffer (Mock, left panels) or with DNase I (right panels) before processing
for staining as described in the Materials and Methods. Green staining depicts Bordetella biofilms formed on top of the host epithelium, which is
stained red.
doi:10.1371/journal.pone.0016861.g006
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microscopy (SEM) to examine the contribution of eDNA to the
stability of in vivo biofilms. Mock treated nasal septa revealed the
presence of thick mats of B. bronchiseptica encased in matrix
material which appeared to completely obscure the underlying
ciliated epithelium (Fig. 7). Treatment with DNase I resulted in
dispersal of the biofilm exposing the ciliated epithelium under-
neath (Fig. 7). We also determined if incubation with DNase I
affected nasal morphology. When observed microscopically, no
gross and overt morphological differences were observed between
nasal septa from naı ¨ve mice that were incubated with either PBS
or DNase I. (Fig. S5). Taken together, results from Figs. 6 and 7
strongly suggest that treatment with DNase I leads to the
detachment of respiratory tract biofilms of both B. bronchiseptica
and B. pertussis.
Discussion
Research on Bordetella biofilm development and macromolecules
that constitute the biofilm matrix is at a very early stage.
Specifically, the function of eDNA in the growth and the
establishment of Bordetella biofilms is not known. One of the
defining characteristics of bacterial biofilms is the presence of an
extracellular matrix composed primarily of extracellular polysac-
charides, embedded proteins and DNA, which provide the
structural scaffold critical for stability of these biofilms
[25,26,40]. Our study has uncovered a critical function for eDNA
as an important structural component for Bordetella biofilm
formation. Strikingly, we found that pre-established late-stage
biofilms formed under static conditions and mature highly
structured biofilms formed under shear forces were quite efficiently
disrupted by DNase I.
The structural role of eDNA in promoting biofilm stability is
highly variable and is dependent on the bacterial species, growth
conditions and age of the biofilm. The relative abundance of DNA
in the biofilm matrix compared to the other polymers does not
appear to be a critical stability determining factor. For reference
strains of P. aeruginosa, while extracellular DNA was the most
abundant matrix polymer in a mature biofilm, exopolysaccharides
appeared to be the most critical structural component [41]. Young
and relatively unstructured biofilms of P. aeruginosa are dissolved
easily by DNase I whereas mature and structured biofilms are
resistant or only marginally affected [42]. For Neisseria meningitidis,
only initial biofilm formation is supported by eDNA [43]. DNase I
appears to have more pronounced effect on mature biofilms
formed by Gram positive bacteria. For Staphylococcus epidermidis it
has been shown that the effect of DNase I on biofilm dispersion
decreased with time and DNase I had a minor effect on biofilms
that were older than 12h [44]. Older biofilms of S. aureus initiated
with high inoculum, and mature biofilms of Enterococcus faecalis and
Listeria monocytogenes are sensitive to DNase I treatment to varying
degrees [35,36,37]. Our finding that DNase I can disrupt a mature
multicellular Bordetella biofilm grown under both static and
hydrodynamic conditions has not been reported previously for
any other Gram negative bacteria. This suggests that unlike many
other Gram negative bacteria, Bordetella utilizes eDNA as a key
component to confer structural stability to biofilms. We have
previously shown that the Bps exopolysaccharide, a component of
the Bordetella biofilm matrix, is critical for the establishment of
mature and structured biofilm [15,17]. It appears the formation of
structured biofilms in Bordetella is dependent on at least two
macromolecules, Bps and eDNA. Based on protein homology of
biosynthetic components and antibody cross-reactivity, Bps is
similar to the poly-b-1,6-N-acetylglucosamine polysaccharides
synthesized by many pathogenic bacteria. These polysaccharides
in other species are partially deacetylated thereby imparting a net
positive charge on the bacterial surface [45,46,47]. The overall
positive charge of these polysaccharides may facilitate interactions
with the negatively charged eDNA. We hypothesize that by
forming a physical complex, eDNA and Bps promote the
Figure 7. Scanning electron microscopy of mock treated (left) or DNase I treated Bordetella biofilms formed in the mouse nose. Nasal
septa were harvested from mice 15 days post-inoculation, excised into two equal parts, treated with either the DNase I buffer (Mock, left panels) or
DNase I (right) followed by processing for SEM as described in the Materials and Methods.
doi:10.1371/journal.pone.0016861.g007
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DNA with polysaccharides has previously been demonstrated. The
b-1,3-glucans polysaccharides specifically interact with certain
polynucleotides to form triple-stranded and helical macromolec-
ular complexes [48]. Similarly eDNA from Caulobacter crescentus
binds to the holdfast polysaccharide, which is composed in part of
b-1,4-N-acetylglucosamine polysaccharides. Interestingly, this
interaction was demonstrated to prevent the settlement of cells
into biofilms and to promote dispersal [31].
The mechanisms of the release and accumulation of eDNA in
biofilms are poorly understood. Autolysis of cells in microcolonies
has been hypothesized to mediate DNA release [49,50]. In E.
faecalis, regulated autolysis by the action of two proteases results in
release of eDNA in biofilm [51]. In Staphylococcus aureus, a finely
tuned holin/antiholin system is thought to mediate cell lysis and
programmed cell death. This system is comprised of the cidAB and
lrgAB operons which encode for proteins that are analogous to
bacteriophage holins and antiholins, respectively [49,52]. It has
been proposed that by differential expression of the Cid and the
Lrg proteins, cell lysis and subsequent release of eDNA is
controlled during biofilm development [49,50,53]. Our data show
that the release of DNA into biofilms is conserved in both B.
bronchiseptica and B. pertussis. Bordetella spp. harbor genes homolo-
gous to cidA and cidB of S. aureus [49]. B. bronchiseptica is considered
the evolutionary progenitor of B. pertussis. Despite this evolutionary
relationship, these two species differ greatly in genome size and
gene expression patterns. B. pertussis has lost close to 1 Mb of the
genome and contains a large number of pseudogenes, many of
which have been inactivated by insertion elements, in-frame stop
codons, and frameshift mutations [54]. Thus, it is reasonable to
speculate that the cid homologues of B. pertussis will be important
for one or more of the virulence characteristics and growth in
hosts. Our future efforts will be directed towards deciphering the
function of the Bordetella cidAB homologues in eDNA release,
biofilm development and virulence.
While it is clear that eDNA plays a critical role in maintaining
the architectural integrity of bacterial biofilms formed on abiotic
surfaces under laboratory conditions, its contribution to biofilm
stability in vivo remains largely unexplored. A network of
extracellular DNA fibers have been visualized in H. influenzae
biofilms formed in the chinchilla middle ear [39,55]. In one of
these studies, even though extracellular DNA was removed on
treatment with DNase I, viable bacteria were still visible in these
biofilms [39]. Our attempts to detect DNA in the mouse
nasopharynx have been unsuccessful. Utilization of stains routinely
used for DNA staining resulted in staining of the entire nasal
epithelium, making it difficult to detect the presence of potential
DNA fibres and the Bordetella cells. In this report, we have obtained
evidence of DNA being responsible for biofilm stability in
mammalian hosts. We found that DNase I treatment of the
mouse nasal septum led to a drastic dissolution of the resident
biofilms suggesting that extracellular DNA is a critical cell-cell
interconnecting macromolecule in respiratory tract biofilms.
To conclude, this study provides further insights into the
mechanisms responsible for biofilm development in Bordetella. Our
results strongly support the role of eDNA in maintaining biofilm
stability and document for the first time the ability of DNase I to
degrade biofilms formed in an animal model of bacterial virulence.
We propose that DNase I represents an accessory option along
with the already approved immunization regimens for the
management and treatment of Bordetella-associated infections in
both humans and animals [56].
Supporting Information
Figure S1 DNase I from different vendors disrupts
preformed Bordetella biofilms. 48 h B. bronchiseptica (RB50)
biofilms formed in 96 well plates were treated with DNase I (100
Kuntz units/ ml) from Promega or Sigma for 1 h. The biofilm was
then stained with crystal violet for quantification at O.D.540. Error
bars represent the standard deviation. Asterisks designate a value
of P,0.05 (students t-test).
(TIF)
Figure S2 Incubation with DNase I does not alter the
growth kinetics of B. bronchiseptica. SS broth was
supplemented with either the DNase I buffer or the buffer plus
DNase I (40 Kuntz units/ ml) followed by inoculation of RB50 at
an O.D.600 of 0.1. The culture tubes were incubated at 37uC with
shaking. At different time points, the O.D.600 was measured for
each culture.
(TIF)
Figure S3 Reversibility of DNase I biofilm disruption.
RB50 was grown in 96 well plates in SS medium with either
DNase I resuspended in the reaction buffer or in the reaction
buffer alone (Mock). Shown as controls are biofilms that were
treated with DNase I for 24h or for 48 h. For one set of DNase I
treated biofilms, the wells were washed with PBS after 24 h
followed by incubation in SS broth for an additional 24 h (24 h
DNase/wash). The biofilm were stained with crystal violet for
quantification at O.D.540. Error bars represent the standard
deviation. Asterisks designate a value of P,0.05 (students
t-test).
(TIF)
Figure S4 DNase I stability. DNase I from Sigma or from
Promega was incubated at 37uC for 48 h in the reaction buffer.
Genomic DNA from RB50 was then treated with either the
DNase I buffer alone (Mock) or with the pre-incubated DNase I
samples at 37uC for 3 h. Samples were run on a 1% agarose gel to
determine if the DNA had been digested by DNase I.
(TIF)
Figure S5 Incubation with DNase I does not alter the
morphology of the mouse nasal septum as observed by
SEM. Nasal septa harvested from naı ¨ve mice were suspended in
PBS followed by treatment at 37uC for 2 h with either the DNase I
buffer (Mock, left panel) or with DNase I resuspended in the
DNase I buffer (DNase I, right panel) followed by visualization
with SEM. Bar, 10mm.
(TIF)
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